Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group.

[1]  J. López-Sendón,et al.  Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. , 1999, Journal of the American College of Cardiology.

[2]  J. Wardrope,et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. , 1999, Journal of accident & emergency medicine.

[3]  J. Dodge,et al.  Impact of injection rate on the Thrombolysis in Myocardial Infarction (TIMI) trial frame count. , 1998, The American journal of cardiology.

[4]  J. Dodge,et al.  Coronary artery injection technique: a quantitative in vivo investigation using modern catheters. , 1998, Catheterization and cardiovascular diagnosis.

[5]  S. Ellis,et al.  Reproducibility of the Corrected TIMI Frame Count in Angiograms of MI Patients Receiving Thrombolysis , 1998 .

[6]  E. Antman,et al.  Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trials , 1998 .

[7]  Bruce R. Brodie,et al.  Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction : In-hospital and 30-day results of the PAMI stent pilot trial , 1998 .

[8]  R. Gibbons,et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review , 1997 .

[9]  E. Antman,et al.  Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow. , 1997, The American journal of cardiology.

[10]  R. Dietz,et al.  Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction. , 1997, Journal of the American College of Cardiology.

[11]  G. Stone,et al.  Primary coronary angioplasty versus thrombolysis. , 1997, The New England journal of medicine.

[12]  M. Simoons,et al.  A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.

[13]  E. Braunwald,et al.  TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. , 1997, Circulation.

[14]  E. Braunwald,et al.  TNK-tissue plasminogen activator compared with front-loaded tissue plasminogen activator in acute myocardial infarction: primary results of the TIMI 10B trial , 1997 .

[15]  C. Gibson,et al.  Techniques in the Angiographic Analysis of Coronary Flow: Past, Present, and Future , 1996 .

[16]  M. Kern,et al.  Determination of angiographic (TIMI grade) blood flow by intracoronary Doppler flow velocity during acute myocardial infarction. , 1996, Circulation.

[17]  W. Weaver,et al.  Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. , 1996, Circulation.

[18]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[19]  A. Vado,et al.  Primary angioplasty versus thrombolysis in inferior acute myocardial infarction with anterior ST-segment depression, a single-center randomized study , 1996 .

[20]  C. Cannon,et al.  Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. , 1994, Journal of the American College of Cardiology.

[21]  J. Ottervanger,et al.  Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. , 1994, Journal of the American College of Cardiology.

[22]  C. Cannon,et al.  A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. , 1994, Journal of the American College of Cardiology.

[23]  C. Peterson.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: Grines CL, Browne KF, Marco J, et al. N Engl J Med 328:673–679 Mar 1993 , 1993 .

[24]  E. Ribeiro,et al.  Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. , 1993, Journal of the American College of Cardiology.

[25]  K. Bailey,et al.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.

[26]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[27]  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[28]  G. A. Murphy,et al.  Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. RAAMI Study Investigators. , 1992, Journal of the American College of Cardiology.

[29]  U. Tebbe,et al.  Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) , 1992, Journal of the American College of Cardiology.

[30]  U. Tebbe,et al.  Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. , 1989, Journal of the American College of Cardiology.

[31]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.